News & Perspective

Mar 20, 2012

Mar 20, 2012

Drug resistance, lack of vaccine top list of TB challenges

(CIDRAP News) – The tuberculosis toll in Europe continued a slow overall decline in 2010, but the treatment success rate for the disease is slipping as drug-resistant strains of TB grow more common, according to a report released today by the European Union (EU) and the World Health Organization (WHO).

Feb 21, 2011

Feb 21, 2011

Flu activity shows signs of receding in Europe

(CIDRAP News) – Influenza activity persists at medium to high levels in most European Union countries but is showing signs of decreasing, according to the latest report from the European Centre for Disease Prevention and Control (ECDC).

Sep 23, 2010

Sep 23, 2010

Probe of suspected vaccine-narcolepsy link to take months

(CIDRAP News) – The European Medicine Agency (EMA) said today it is not clear if there is any link between narcolepsy cases and the Pandemrix vaccine for 2009 H1N1 influenza, and it will take 3 to 6 months to investigate the possibility fully.

Nov 04, 2009

Nov 04, 2009

H1N1 FLU BREAKING NEWS: OTC antivirals, Ukraine aid, Amazon tribe struck, pain relievers and vaccine, cat has H1N1

 

Norway OKs OTC antiviral salesTo ease response to the H1N1 pandemic, Norway is allowing over-the-counter sales of oseltamivir (Tamiflu) and zanamivir (Relenza), the Associated Press (AP) reported. The new policy starts tomorrow and is in effect until the middle of 2010. Norway has ordered 9.4 million doses of vaccine, but the manufacturer has reportedly not produced enough to meet demand.

Jun 13, 2007

Jun 13, 2007

EU approves Novartis's cell-based flu vaccine

(CIDRAP News) – The European Union (EU) has approved Novartis's seasonal influenza vaccine, Optaflu, putting the Swiss company in a position to become the first to market a flu vaccine grown in cell culture rather than eggs.

Feb 23, 2007

Feb 23, 2007

Afghanistan confirms new H5N1 outbreaks

(CIDRAP News) – Afghanistan confirmed yesterday that poultry deaths at two farms in the eastern part of the country were caused by highly pathogenic H5N1 avian influenza.

Sep 19, 2006

Sep 19, 2006

Sanofi tests H7N1 flu vaccine for pandemic readiness

(CIDRAP News) – Sanofi Pasteur today announced the start of the first clinical trial of an H7N1 influenza vaccine, intended to guard against the threat of a pandemic caused by H7 strains of avian influenza.

Current concern about a flu pandemic focuses mainly on the H5N1 avian flu virus, which has infected at least 247 people and killed 144. But H7 avian flu viruses have caused a number of mild illness cases and one death in the past 3 years.

Apr 24, 2006

Apr 24, 2006

Study cites gaps in Europe's flu pandemic plans

(CIDRAP News) – European countries' plans for coping with an influenza pandemic are generally good but have a number of gaps, including a lack of detail on distribution of drugs and supplies, according to an analysis published last week by The Lancet.

Oct 28, 2005

Oct 28, 2005

Chiron wins H5N1 vaccine contract; WHO says virus is changing

(CIDRAP News) – The US government has awarded Chiron Corp. a $62.5 million contract to make a vaccine for H5N1 avian influenza as part of efforts to prepare for a possible human flu pandemic.

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»